Plain-English translation of NCT05610631 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research registry — a database where patients with pulmonary hypertension (a condition affecting blood pressure in the lungs) can share their medical information and health records. Researchers in Switzerland are building this registry to learn more about the different types of pulmonary hypertension, how they progress, and what treatments work best. By joining, you help scientists understand this condition more deeply and potentially improve care for future patients.
Pulmonary hypertension is a complex condition with several different types, and doctors need better information about how each type develops and responds to treatment. This registry will help researchers identify patterns, improve diagnosis, and develop better therapies across all types of pulmonary hypertension.
You likely qualify if…
You likely don't qualify if…
As a participant, you would give permission for researchers to access and review your medical records related to your pulmonary hypertension diagnosis and treatment. This is an observational registry, meaning you are not required to take any new medication or undergo any special procedures — researchers simply collect data from your existing medical care. The registry follows patients over time to track how the condition changes and how different treatments work.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Switzerland
Actelion
Enrollment target
~1,000 participants
Started
June 2017
Primary completion
December 2027
Last updated on clinicaltrials.gov in November 2022.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Silvia Ulrich, Prof. Dr.
UniversityHospital Zurich
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.